Last updated: August 18, 2010
Sponsor: Southern Arizona VA Health Care System
Overall Status: Trial Status Unknown
Phase
2/3
Condition
Heartburn
Heartburn (Pediatric)
Gastroesophageal Reflux Disease (Gerd)
Treatment
N/AClinical Study ID
NCT01089959
ISS Astra Zeneca 7 day Nexium
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Nocturnal symptoms at least twice a week.
Ages 18-80
Erosive esophagitis and/or abnormal pH test -
Able to read, understand, and complete study questionnaires
Exclusion
Exclusion Criteria:
Subjects with Barrett's esophagus or peptic stricture on endoscopy
Subjects with normal endoscopy and pH test
Subjects with previous upper gastrointestinal surgery
Study Design
Total Participants: 20
Study Start date:
March 01, 2010
Estimated Completion Date:
March 31, 2012
Study Description
Connect with a study center
Southern Arizona VA Health Care System
Tucson, Arizona 85723
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.